| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |